Compositions and methods for treating multiple sclerosis

Details for Australian Patent Application No. 2009241365 (hide)

Owner Revalesio Corporation

Inventors Watson, Richard L.; Archambeau, Gregory J.; Wood, Anthony B.

Agent Davies Collison Cave

Pub. Number AU-A-2009241365

PCT Pub. Number WO2009/134728

Priority 12/258,210 24.10.08 US; 61/048,332 28.04.08 US; 61/048,347 28.04.08 US; 12/256,774 23.10.08 US; PCT/ US2008/081021 23.10.08 US; PCT/ US2008/081202 24.10.08 US

Filing date 27 April 2009

Wipo publication date 5 November 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 5/071 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Vertebrate cells or tissues, e.g. human cells or tissues

Event Publications

23 December 2010 PCT application entered the National Phase

  PCT publication WO2009/134728 Priority application(s): WO2009/134728

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009241376-Automatic transport loading system and method

2009241360-Progesterone antagonists such as CDB-4124 in the treatment of breast cancer